skip to page content
Talk to the Veterans Crisis Line now
U.S. flag
An official website of the United States government

Health Services Research & Development

Go to the ORD website
Go to the QUERI website

2008 HSR&D National Meeting Abstract

National Meeting 2008

1043 — The VA Project to Implement Diuretics (VAPID): A Patient-Oriented Intervention Study

Kaboli PJ (Center for Research in the Implementation of Innovative Strategies in Practice (CRIISP), Iowa City VAMC), Ishani A (Minneapolis VAMC), Wilson H (CRIISP, Iowa City VAMC), VanderWeg M (CRIISP, Iowa City VAMC), Carter BL (CRIISP, Iowa City VAMC), Christensen A (CRIISP, Iowa City VAMC)

Evidence-based guidelines recommend thiazide diuretics as first-line therapy for uncomplicated hypertension; however, thiazides remain under-utilized. The objective of our study was to test the efficacy of a patient-oriented intervention to initiate thiazides.

383 eligible hypertensive patients from 12 VA clinics not taking a thiazide and either previously not at blood pressure (BP) goal (uncontrolled HTN) or at goal and taking a calcium channel blocker (controlled CCB), which is not first-line therapy, were enrolled. Patients were randomized to a control group or three intervention groups designed to activate patients to talk to their providers about thiazides: Group A received an activation letter, Group B the letter with financial incentives, and Group C the letter, financial incentives, and reminder phone call. Outcomes were: 1) patient-initiated hypertension discussion and 2) thiazide prescribing.

Overall, the intervention resulted in Group A, B, and C discussion rates of 51%, 54%, and 71% (P < .001) with thiazide prescribing rates of 23%, 25%, and 32% (P < .001). In the uncontrolled HTN sub-group (N=184), Group A, B, and C discussion rates were 47%, 48%, and 75% (P < .001) with thiazide prescribing rates of 31%, 25%, and 32% (P < .01). In the controlled CCB sub-group (N=69), Group A, B, and C discussion rates were 57%, 74%, and 59% (P < .01) with thiazide prescribing rates of 7%, 26%, and 32% (P < .01). The control group (N=130) thiazide prescription rate was 2.6%; all groups were significantly different from controls (P < 0.01). Patients not at BP goal were more likely to initiate thiazides than those at goal (OR 5.2, 95%CI 3.0-9.0). Of note, 51% of uncontrolled HTN patients had controlled BP at their clinic visit without change in their hypertension treatment.

Providing patient-oriented information about thiazides for hypertension resulted in half of patients initiating discussions and one-fourth starting or switching to a thiazide, with a greater effect in uncontrolled patients than controlled patients. Adding a financial incentive and reminder phone call to the letter resulted in modest, but inconsistent, increases in both outcomes.

This low-cost, low-intensity, patient-activation intervention resulted in high rates of patient-initiated discussions and thiazide treatment. Future studies should investigate patient-activation to promote other areas of evidence-based medicine.

Questions about the HSR&D website? Email the Web Team

Any health information on this website is strictly for informational purposes and is not intended as medical advice. It should not be used to diagnose or treat any condition.